Press Releases
- July 19, 2010
- Lorus Therapeutics Announces FDA Approval to Initiate Phase I Clinical Trial for First-in-Class Cancer Drug LOR-253 [PDF: 45 Kb]
- June 14, 2010
- Lorus Therapeutics Announces Presentation of Phase II Clinical Trial Data for LOR-2040 in Acute Myeloid Leukemia [PDF: 259 Kb]
- June 3, 2010
- Lorus Therapeutics Announces Filing of Preliminary Short Form Prospectus [PDF: 280 Kb]
- June 1, 2010
- Lorus Therapeutics Files Investigational New Drug Application with FDA for Anticancer Drug LOR-253 [PDF: 269 Kb]
- May 25, 2010
- Lorus Therapeutics Announces Completion of Share Consolidation [PDF: 52 Kb]
- May 18, 2010
- Lorus Therapeutics Announces Patent Allowance for Lead Small Molecule Drugs [PDF: 258 Kb]
- May 15, 2010
- Lorus Therapeutics Announces Timing of Share Consolidation [PDF: 62 Kb]
- May 13, 2010
- Lorus Therapeutics Announces Share Consolidation [PDF: 294 Kb]
- May 3, 2010
- Lorus Therapeutics Announces Allowance of Patent for LOR-2040 in the Treatment of Acute Myeloid Leukemia [PDF: 257 Kb]
- April 27, 2010
- Lorus Therapeutics Obtains Listing on OTCBB in the United States [PDF: 266 Kb]
- April 14, 2010
- Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2010 [PDF: 283 Kb]
- April 12, 2010
- Lorus Therapeutics Announces Successful Production of First Clinical Batch of Anticancer drug LOR-253 [PDF: 256 Kb]
- April 6, 2010
- Lorus Therapeutics Files Registration Statement with SEC [PDF: 264 Kb]
- March 10, 2010
- Lorus Therapeutics Announces Allowance of a Patent on its Small Molecule Program [PDF: 257 Kb]
- March 4, 2010
- Lorus Therapeutics Announces Resignation of Director [PDF: 287 Kb]
- February 24, 2010
- Lorus Announces Publication Demonstrating Antitumor Efficacy of Interleukin 17E [PDF: 259 Kb]
- January 14, 2010
- Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2010 [PDF: 337 Kb]